by Benzinga Insights | Jan 5, 2026 | General
Synopsys (NASDAQ:SNPS) has outperformed the market over the past 10 years by 14.58% on an annualized basis producing an average annual return of 28.11%. Currently, Synopsys has a market capitalization of $92.77 billion. Buying $1000 In SNPS: If an investor had bought...
by Benzinga Insights | Jan 5, 2026 | General
S&P Global (NYSE:SPGI) has outperformed the market over the past 10 years by 6.06% on an annualized basis producing an average annual return of 19.57%. Currently, S&P Global has a market capitalization of $160.47 billion. Buying $100 In SPGI: If an investor...
by Avi Kapoor | Jan 5, 2026 | General
Constellation Brands, Inc. (NYSE:STZ) will release earnings results for the third quarter after the closing bell on Wednesday, Jan. 7, 2025. Analysts expect the company to report quarterly earnings at $2.64 per share, down from $3.25 per share in the year-ago period....
by Vandana Singh | Jan 5, 2026 | General
Zenas BioPharma Inc. (NASDAQ:ZBIO) stock is trading lower on Monday after the company released results from the Phase 3 INDIGO trial of obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD). IgG4-RD is an immune system disorder where the body creates excess IgG4...
by Benzinga Insights | Jan 5, 2026 | General
Lam Research (NASDAQ:LRCX) has outperformed the market over the past 20 years by 12.76% on an annualized basis producing an average annual return of 21.49%. Currently, Lam Research has a market capitalization of $242.95 billion. Buying $1000 In LRCX: If an investor...
Recent Comments